APA-Zitierstil (7. Ausg.)

Thaler, S., & Sleeman, J. P. (2015). The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor‐positive breast cancer. International journal of cancer, 137(3), . https://doi.org/10.1002/ijc.29404

Chicago-Zitierstil (17. Ausg.)

Thaler, Sonja, und Jonathan P. Sleeman. "The Proteasome Inhibitor Bortezomib (Velcade) as Potential Inhibitor of Estrogen Receptor‐positive Breast Cancer." International Journal of Cancer 137, no. 3 (2015). https://doi.org/10.1002/ijc.29404.

MLA-Zitierstil (9. Ausg.)

Thaler, Sonja, und Jonathan P. Sleeman. "The Proteasome Inhibitor Bortezomib (Velcade) as Potential Inhibitor of Estrogen Receptor‐positive Breast Cancer." International Journal of Cancer, vol. 137, no. 3, 2015, https://doi.org/10.1002/ijc.29404.